S

Singapore Paincare Holdings Ltd
SGX:FRQ

Watchlist Manager
Singapore Paincare Holdings Ltd
SGX:FRQ
Watchlist
Price: 0.089 SGD 5.95% Market Closed
Market Cap: S$16m

Singapore Paincare Holdings Ltd
Revenue

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Singapore Paincare Holdings Ltd
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
S
Singapore Paincare Holdings Ltd
SGX:FRQ
Revenue
S$26m
CAGR 3-Years
11%
CAGR 5-Years
22%
CAGR 10-Years
N/A
Raffles Medical Group Ltd
SGX:BSL
Revenue
S$765.3m
CAGR 3-Years
-2%
CAGR 5-Years
6%
CAGR 10-Years
6%
Livingstone Health Holdings Ltd
SGX:PRH
Revenue
S$29m
CAGR 3-Years
-6%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Thomson Medical Group Ltd
SGX:A50
Revenue
S$408.7m
CAGR 3-Years
3%
CAGR 5-Years
14%
CAGR 10-Years
17%
HC Surgical Specialists Ltd
SGX:1B1
Revenue
S$18.9m
CAGR 3-Years
0%
CAGR 5-Years
1%
CAGR 10-Years
N/A
No Stocks Found

Singapore Paincare Holdings Ltd
Glance View

Market Cap
16m SGD
Industry
N/A

Singapore Paincare Holdings Ltd. is an investment holding company, which engages in the healthcare services. The firm also collaborates with primary care providers to provide pain care treatments to heartland-located medical clinics. The Company’s pain care conditions include neck pain, lower back pain, spinal stenosis, body pain (fibromyalgia), frozen shoulder, osteoarthritis knee pain, heel pain (plantar fasciitis) treatment and tennis elbow. In addition, the Company provides pain treatment such as primary care and other services, platelet rich plasma, neuroplasty, myofascial pain injections, nucleoplasty, radio frequency ablation, intrathecal pump implants, pulsed radio frequency, spinal cord stimulator and endoscopic. The Company’s services include GP medical and pain care, specialist pain care, specialist advisory panel, physiotherapy, cancer screening and treatment and traditional Chinese medicine.

FRQ Intrinsic Value
0.15 SGD
Undervaluation 41%
Intrinsic Value
Price S$0.089
S

See Also

What is Singapore Paincare Holdings Ltd's Revenue?
Revenue
26m SGD

Based on the financial report for Jun 30, 2025, Singapore Paincare Holdings Ltd's Revenue amounts to 26m SGD.

What is Singapore Paincare Holdings Ltd's Revenue growth rate?
Revenue CAGR 5Y
22%

Over the last year, the Revenue growth was -3%. The average annual Revenue growth rates for Singapore Paincare Holdings Ltd have been 11% over the past three years , 22% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett